• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number D134805
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Cardiac Perforation (2513)
Event Date 03/04/2024
Event Type  Injury  
Manufacturer Narrative
On 20-mar-2024, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a patient underwent an atrial fibrillation ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced cardiac perforation that required medication and prolonged hospitalization.It was reported by the caller that during a procedure an adverse event occurred.A pericardial effusion caused by a perforation was discovered using intracardiac echocardiography (ice).They confirmed the effusion using an x-ray, echocardiogram, and another cardiologist's assessment.The medical intervention provided was medication administration and the patient was moved to the intensive care unit to be monitored.Multiple attempts have been made to obtain clarification to this complaint.However, no further information has been made available.
 
Manufacturer Narrative
It was reported that a patient underwent an atrial fibrillation ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced cardiac perforation that required medication and prolonged hospitalization.It was reported by the caller that during a procedure an adverse event occurred.A pericardial effusion caused by a perforation was discovered using intracardiac echocardiography (ice).They confirmed the effusion using an x-ray, echocardiogram, and another cardiologist's assessment.The medical intervention provided was medication administration and the patient was moved to the intensive care unit to be monitored.Device evaluation details: the product was returned to biosense webster (bwi) for evaluation and the product evaluation was completed on 2-apr-2024.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4) correction: on 29-mar-2024, it was discovered the following information was inadvertently omitted from the 3500a initial medwatch report: ¿the physician¿s opinion on the cause of the adverse event is that it was procedure related.Transeptal puncture was performed with a baylis needle.Ablation was performed prior to noting the pericardial effusion.There was no evidence of steam pop.No error messages observed on biosense webster equipment during the procedure.Correct catheter settings were selected on the generator and the pump was switching from low to high flow during ablation.¿ in addition, the initial reporter details and additional concomitant product details were also omitted, as such, they have now been added to the respective fields.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key18984304
MDR Text Key338660735
Report Number2029046-2024-01030
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010183
UDI-Public10846835010183
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberD134805
Device Lot Number31233473L
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/29/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/02/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BAYLIS TRANSSEPTAL NEEDLE; CARTO 3 SYSTEM; DECANAV CATHETER: 31229799M/ REF: R7D282CT; ICE CATHETER; UNKNOWN GENERATOR; UNKNOWN PUMP; VIZIGO SHEATH
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient SexMale
-
-